Sackley C, Rick C, Brady M, Burton C, Jowett S, Patel S
Health Technol Assess. 2024; 28(58):1-141.
PMID: 39364774
PMC: 11474952.
DOI: 10.3310/ADWP8001.
Cho S, Agmon G, Shellikeri S, Cousins K, Ash S, Irwin D
Speech Prosody. 2022; 2022:120-124.
PMID: 36444200
PMC: 9701527.
DOI: 10.21437/speechprosody.2022-25.
Sackley C, Rick C, Au P, Brady M, Beaton G, Burton C
Trials. 2020; 21(1):436.
PMID: 32460885
PMC: 7251680.
DOI: 10.1186/s13063-020-04354-7.
Sackley C, Smith C, Rick C, Brady M, Ives N, Patel S
Pilot Feasibility Stud. 2018; 4:30.
PMID: 29344405
PMC: 5763537.
DOI: 10.1186/s40814-017-0222-z.
Fullard M, Thibault D, Hill A, Fox J, Bhatti D, Burack M
Neurology. 2017; 89(11):1162-1169.
PMID: 28835397
PMC: 5595277.
DOI: 10.1212/WNL.0000000000004355.
Bigdata Oriented Multimedia Mobile Health Applications.
Lv Z, Chirivella J, Gagliardo P
J Med Syst. 2016; 40(5):120.
PMID: 27020918
DOI: 10.1007/s10916-016-0475-8.
Listener Perception of Monopitch, Naturalness, and Intelligibility for Speakers With Parkinson's Disease.
Anand S, Stepp C
J Speech Lang Hear Res. 2015; 58(4):1134-44.
PMID: 26102242
PMC: 4765198.
DOI: 10.1044/2015_JSLHR-S-14-0243.
Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trial.
Sackley C, Smith C, Rick C, Brady M, Ives N, Patel R
Trials. 2014; 15:213.
PMID: 24908096
PMC: 4059086.
DOI: 10.1186/1745-6215-15-213.
Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.
Herd C, Tomlinson C, Deane K, Brady M, Smith C, Sackley C
Cochrane Database Syst Rev. 2012; (8):CD002814.
PMID: 22895931
PMC: 7120320.
DOI: 10.1002/14651858.CD002814.pub2.
Translating principles of neural plasticity into research on speech motor control recovery and rehabilitation.
Ludlow C, Hoit J, Kent R, Ramig L, Shrivastav R, Strand E
J Speech Lang Hear Res. 2008; 51(1):S240-58.
PMID: 18230849
PMC: 2364711.
DOI: 10.1044/1092-4388(2008/019).
Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study.
El Sharkawi A, Ramig L, Logemann J, Pauloski B, Rademaker A, Smith C
J Neurol Neurosurg Psychiatry. 2002; 72(1):31-6.
PMID: 11784821
PMC: 1737706.
DOI: 10.1136/jnnp.72.1.31.
Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.
Ramig L, Sapir S, Countryman S, Pawlas A, OBrien C, Hoehn M
J Neurol Neurosurg Psychiatry. 2001; 71(4):493-8.
PMID: 11561033
PMC: 1763504.
DOI: 10.1136/jnnp.71.4.493.
Speech and language therapy: does it work?.
Enderby P, Emerson J
BMJ. 1996; 312(7047):1655-8.
PMID: 8664724
PMC: 2351353.
DOI: 10.1136/bmj.312.7047.1655.
Parkinson's disease.
Marsden C
J Neurol Neurosurg Psychiatry. 1994; 57(6):672-81.
PMID: 7755681
PMC: 1072968.
DOI: 10.1136/jnnp.57.6.672.
The response of the apparent receptive speech disorder of Parkinson's disease to speech therapy.
Scott S, CAIRD F
J Neurol Neurosurg Psychiatry. 1984; 47(3):302-4.
PMID: 6707678
PMC: 1027731.
DOI: 10.1136/jnnp.47.3.302.
Evidence for an apparent sensory speech disorder in Parkinson's disease.
Scott S, CAIRD F, Williams B
J Neurol Neurosurg Psychiatry. 1984; 47(8):840-3.
PMID: 6470725
PMC: 1027948.
DOI: 10.1136/jnnp.47.8.840.
Parkinson's disease: disability, review, and management.
Mutch W, Strudwick A, Roy S, DOWNIE A
Br Med J (Clin Res Ed). 1986; 293(6548):675-7.
PMID: 3092977
PMC: 1341520.
DOI: 10.1136/bmj.293.6548.675.
The interpretation of dysprosody in patients with Parkinson's disease.
Caekebeke J, Jennekens-Schinkel A, van der Linden M, Buruma O, Roos R
J Neurol Neurosurg Psychiatry. 1991; 54(2):145-8.
PMID: 2019840
PMC: 1014349.
DOI: 10.1136/jnnp.54.2.145.